Abstract:BACKGROUND AND OBJECTIVE: To systematically review studies of laser treatment of infantile hemangioma (IH).STUDY DESIGN/METHODS AND MATERIALS: We searched multiple databases including MEDLINE® and EMBASE from 1982 to June 2015. Two investigators independently screened studies against predetermined criteria and extracted key data. Investigators independently assessed study risk of bias and the strength of the evidence of the body of literature.RESULTS: We identified 29 studies addressing lasers: 4 randomized controlled trials, 8 retrospective cohort studies, and 17 case series. Lasers varied across studies in type, pulse width, or cooling materials. Most comparative studies (n = 9) assessed variations of pulsed dye laser (PDL) and examined heterogeneous endpoints. Most studies reported on treatment of cutaneous lesions. Overall, longer pulse PDL with epidermal cooling was the most commonly used laser for cutaneous lesions; Nd:YAG was the most commonly used intralesionally. Most studies reported a higher success rate with longer pulse PDL compared with observation in managing the size of IH, although the magnitude of effect differed substantially. CO2 laser was used for subglottic IH in a single study, and was noted to have a higher success rate and lower complication rate than both Nd:YAG and observation. Studies comparing laser with β-blockers or in combination with β-blockers reported greater improvements in lesion size in combination arms versus β-blockers alone and greater effects of lasers on mixed superficial and deep IH. Strength of the evidence for outcomes after laser treatments ranged from insufficient to low for effectiveness outcomes. Strength of the evidence was insufficient for the effects of laser compared with β-blockers or in combination with β-blockers as studies evaluated different agents and laser types. Studies assessing outcomes after CO2 and Nd:YAG lasers typically reported some resolution of lesion size, but heterogeneity among studies limits our abilities to draw conclusions.CONCLUSION: Studies of laser treatment of IH primarily addressed different laser modalities compared with observation or other laser modalities. PDL was the most commonly studied laser type, but multiple variations in treatment protocols did not allow for demonstration of superiority of a single method. Most studies reported a higher success rate with longer pulse PDL compared to observation in managing the size of IH, although the magnitude of effect differed substantially. Studies generally found PDL more effective than other types of lasers for cutaneous lesions. When first introduced as a primary treatment for IH, various laser modalities generally offered superior outcomes compared with steroid therapy and observation. In the era of β-blocker therapy, laser treatment may retain an important role in the treatment of residual and refractory lesions.

Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma

Combination of Sclerotherapy and Dual-Wavelength Laser in the Management of Infantile Hemangiomas in Chinese Infants.

Open-Label Nonrandomized Left-Right Comparison of Imiquimod 5% Ointment and Timolol Maleate 0.5% Eye Drops in the Treatment of Proliferating Superficial Infantile Hemangioma

Infantile Hemangioma: Clinical Characteristics and Efficacy of Treatment with the Long-Pulsed 1,064-Nm Neodymium-Doped Yttrium Aluminum Garnet Laser in 794 Chinese Patients

Prospective, Open-Label, Rater-Blinded and Self-Controlled Pilot Study of the Treatment of Proliferating Superficial Infantile Hemangiomas with 0.5% Topical Timolol Cream Versus 595-Nm Pulsed Dye Laser

Effect of Timolol Maleate Gel-forming Solution in the Treatment of Superficial Infantile Hemangiomas: a Prospective, Randomized, Double-Blind, Controlled Trial

Comparison of Simply Topical Timolol 0.5% Cream and Combined with Intralesional Diprospan Injection for the Treatment of Thick Superficial Infantile Hemangiomas

Imiquimod 5% Cream Versus Timolol 0.5% Ophthalmic Solution for Treating Superficial Proliferating Infantile Haemangiomas: a Retrospective Study

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.

Efficacy of Pulsed Dual-Wavelength 595 and 1064 Nm Laser in Treatment of Superficial Infantile Hemangioma

A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.

Fractional Carbon Dioxide Laser-Assisted Drug Delivery of Topical Timolol Solution for the Treatment of Deep Infantile Hemangioma: a Pilot Study.

Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: a meta‐analysis of 10 studies

Laser treatment of infantile hemangioma: A systematic review

Concurrent versus sequential combination of propranolol and dual-wavelength laser ( 585 nm and 1064 nm ) to treat complicated infantile hemangiomas

Predictors of Treatment Responses of Superficial Infantile Hemangiomas to Topical Timolol.

Comprehensive Management of Infantile Hemangiomas Involving the Periorbital Region.

Progress In The Treatment Of Infantile Hemangioma

The Efficacy and Safety of Treatments for Infantile Hemangiomas: a Bayesian Network Meta‐analysis

A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.

Pulsed Dye Laser Treatment in Infantile Hemangioma